Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroaki Taguchi

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|November 1, 2008
Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffoldsHiroaki Taguchi, Stephanie Planque, Gopal Sapparapu, et al.
Molecular Biotechnology|October 5, 2007
Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodiesYukie Mitsuda, Stephanie Planque, Mariko Hara, et al.
ACR Open Rheumatology|December 20, 2023
Clinical Images: Epistaxis may be a warning sign of lymphoproliferative disorder during methotrexate treatment for dermatomyositisSho Ishigaki, Nobuhiko Kajio, Mikio Okayama, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 18, 2016
[A Case of Leptospirosis in which the Causative Pathogen was Detected Using Cerebrospinal Fluid PCR Eight Days after Onset]Yuki Arita, Toshihiro Tono, Tomohiro Hosoda, et al.
The Journal of Biological Chemistry|August 31, 2007
Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analogYasuhiro Nishiyama, Yukie Mitsuda, Hiroaki Taguchi, et al.
Springer Seminars in Immunopathology|January 6, 2005
Antibodies as defensive enzymesSudhir Paul, Yasuhiro Nishiyama, Stephanie Planque, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
A mechanism-based probe for gp120-Hydrolyzing antibodiesHiroaki Taguchi, Gary Burr, Sangeeta Karle, et al.
The Journal of Biological Chemistry|December 17, 2003
Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodiesYasuhiro Nishiyama, Gita Bhatia, Yogesh Bangale, et al.
RMD Open|January 27, 2017
Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective studyChihiro Takahashi, Yuko Kaneko, Yutaka Okano, et al.
Archives of Biochemistry and Biophysics|June 8, 2002
Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogsYasuhiro Nishiyama, Hiroaki Taguchi, Jin-Quan Luo, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|November 1, 2008
Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffoldsHiroaki Taguchi, Stephanie Planque, Gopal Sapparapu, et al.
Molecular Biotechnology|October 5, 2007
Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodiesYukie Mitsuda, Stephanie Planque, Mariko Hara, et al.
ACR Open Rheumatology|December 20, 2023
Clinical Images: Epistaxis may be a warning sign of lymphoproliferative disorder during methotrexate treatment for dermatomyositisSho Ishigaki, Nobuhiko Kajio, Mikio Okayama, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 18, 2016
[A Case of Leptospirosis in which the Causative Pathogen was Detected Using Cerebrospinal Fluid PCR Eight Days after Onset]Yuki Arita, Toshihiro Tono, Tomohiro Hosoda, et al.
The Journal of Biological Chemistry|August 31, 2007
Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analogYasuhiro Nishiyama, Yukie Mitsuda, Hiroaki Taguchi, et al.
Springer Seminars in Immunopathology|January 6, 2005
Antibodies as defensive enzymesSudhir Paul, Yasuhiro Nishiyama, Stephanie Planque, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
A mechanism-based probe for gp120-Hydrolyzing antibodiesHiroaki Taguchi, Gary Burr, Sangeeta Karle, et al.
The Journal of Biological Chemistry|December 17, 2003
Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodiesYasuhiro Nishiyama, Gita Bhatia, Yogesh Bangale, et al.
RMD Open|January 27, 2017
Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective studyChihiro Takahashi, Yuko Kaneko, Yutaka Okano, et al.
Archives of Biochemistry and Biophysics|June 8, 2002
Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogsYasuhiro Nishiyama, Hiroaki Taguchi, Jin-Quan Luo, et al.
Pageof 7